Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ADPT Adaptive Biotechnologies Corporation

5,64

-0,04 (-0,70%)

Zuletzt aktualisiert: 19:59:38

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Adaptive Biotechnologies Charts.

Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Adaptive Biotechnologies Charts.

News Adaptive Biotechnologies Corporation

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 20 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
Donnerstag 7 November 2024 (3 Wochen vor) • GlobeNewswire Inc.

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
Donnerstag 7 November 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 10 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
Mittwoch 9 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Adaptive Announces IVDR Certification for clonoSEQ® in European Union
Donnerstag 29 August 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 22 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Adaptive Biotechnologies Corporation News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen